What is LOPJLB’s current signal on CCCC?

LOPJLB’s latest quantitative signal on C4 Therapeutics, Inc. (CCCC) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is CCCC in?

C4 Therapeutics, Inc. (CCCC) is currently classified in the CRISIS HMM market regime on LOPJLB.

Where is C4 Therapeutics, Inc. based / listed?

C4 Therapeutics, Inc. is based in US, listed on NASDAQ.

C4 Therapeutics, Inc. (CCCC)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$2.85+1.06%Close

SELLCRISIS · day 5

RANGE

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-15

Market cap: $315M
Beta: 3.08
P/E (TTM): -2.88

Short % float: 48.01%
Days to cover: 22.7
SI change: +7.4%

1W: -9.24%
1M: -17.15%

vs SPY 1W: -10.79%
vs SPY 1M: -18.92%

Industry peers

FMP comparable companies · ranked by market cap

OABIBUYOmniAb, Inc.$706MCRISISQ -11$4.87+2.19%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Company

C4 Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapeutic candidates. Its core strategy involves degrading proteins implicated in disease, addressing a range of conditions including cancer, neurodegenerative…

Employees: 104
Headquarters: US
Founded: 2020
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares out: 110.6M
Float: 75.7%

c4therapeutics.com ↗

Key executives

Andrew J. Hirsch — Chief Executive Officer, President & Director

Leonard J. Reyno — Chief Medical Officer

Kendra Adams — Principal Accounting Officer, CFO, Head of Corporate Affairs & Treasurer

SEC filings

EDGAR · CIK 16625790 · CCCC

Analyst consensus

Buy

Bullish1071.4%

Neutral321.4%

Bearish17.1%

L $6.00Avg $11.33H $20.00

Target$11.33+297.54%

Last$2.85

Key stats

Industry peers

Prediction markets

Company news